The Iodine Deficiency Drug market size is expected to reach $314.08 billion by 2030 at a CAGR of 10.1%, driven by increasing insufficient iodine intake.
The Intracranial Hematoma Drug market size is expected to reach $2.79 billion by 2030 at a CAGR of 9.7%, driven by rising incidence of traumatic brain injuries.
The Clinical Trials market size is expected to reach $176.32 billion in 2030 at a CAGR of 6.8%, driven by new drug development demand.
The life science market is projected to reach $200.59B by 2030 at 12.9% CAGR, driven by precision medicine, AI analytics, digital health, clinical trials, and drug discovery platforms.
Test Message
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.